AI-Powered Knowledge Graphs for Next-Generation Biomedical Decisions

Live Webinar June 18th 10 a.m. ET / 4 p.m. CET

Biomedical research is generating data at an unprecedented scale, and the ability to connect this information meaningfully has become essential for accelerating discovery. Knowledge graphs offer a powerful solution by integrating highly heterogeneous datasets into a single, interpretable network. By uncovering relationships across genes, pathways, diseases, drugs, biomarkers, adverse events, and clinical evidence, they enable intuitive exploration, explainable insights, and scalable analytics that directly support target discovery, mechanism of action studies, safety assessment, and translational research.

In this webinar, we will introduce a biomedical knowledge graph, a high quality, curated resource containing more than 2.4 million nodes and over 10 million edges, integrating trusted Clarivate content from CDDI, MetaBase and OFF X. The graph is built to combine proprietary, public, and client generated data into a unified framework, capturing curated relationships across biology, chemistry, and clinical evidence. This makes it a strong foundation not only for hypothesis generation and exploratory analysis, but also for downstream machine learning, AI driven analytics, and graph based applications such as retrieval augmented generation.

The webinar will answer the following questions:
  • What are the key advantages of using knowledge graphs for biomedical research?
  • What differentiates Clarivate’s biomedical knowledge graph from other approaches?
  • How can AI and natural language querying be applied to explore complex biomedical data?

Explore AI-Powered Knowledge Graphs

HIDDEN FIELDS BELOW

Moderator

Matt Wampole, Director, Solution Consulting

Matt Wampole is the Director of Solution Consulting at Clarivate where he and his team support clients from discovery to launch of new medical interventions. His 20 years of experience have covered a broad range of topics across drug discovery and optimization, clinical trial optimization, regulatory intelligence, and business development. What excites him the most is how unifying disparate datasets with new technologies like AI/ML and GenAI will lead to new treatments for unmet medical needs.

Expert Speaker Gaia Ceddia, Manager, Discovery and Translational Science, Clarivate

Gaia Ceddia is a Manager at Clarivate, where she supports translational research through spatial transcriptomics analytics, biomedical knowledge graphs, and applied machine learning. Her work spans production‑grade pipeline development, method benchmarking, and graph‑based data integration and analysis.

Expert Speaker Anton Kichev, Senior Consultant, Discovery and Translational Science, Clarivate

Anton is a Senior Consultant with over 5 years of experience providing bioinformatics support to Clarivate customers, focusing on the analysis of clinical trial data, drug development, drug repurposing, and mechanisms of action. He also has more than 20 years of experience in life sciences, molecular biology, and cellular biology, with a strong emphasis on neuroscience.